期刊论文详细信息
BMC Public Health
The economic burden of angina on households in South Asia
Ajay Mahal2  Khurshid Alam1 
[1] Centre for Equity and Health Systems, ICDDR,B, 68 Shaheed Tajuddin Ahmed Sharani, Mohakhali, Dhaka 1212, Bangladesh;Monash School of Public Health & Preventive Medicine, Monash University, 99 Commercial Road, The Alfred Centre, Melbourne, Vic, 3004, Australia
关键词: South Asia;    Households;    Non-medical consumption expenditure;    Employment status;    Borrowing or selling assets;    Catastrophic expenses;    OOP health spending;    Diagnosed angina;    Symptomatic angina;   
Others  :  1132541
DOI  :  10.1186/1471-2458-14-179
 received in 2013-03-20, accepted in 2014-02-17,  发布年份 2014
PDF
【 摘 要 】

Background

Globally, an estimated 54 million people have angina, 16 million of whom are from the WHO South-East Asia region. Despite the increasing burden of cardiovascular disease (CVD) in South Asia, there is no evidence of an economic burden of angina on households in this region. We investigated the economic burden of angina on households in South Asia.

Methods

We applied a novel propensity score matching approach to assess the economic burden of angina on household out-of-pocket (OOP) health spending, borrowing or selling assets, non-medical consumption expenditure, and employment status of angina-affected individual using nationally representative World Health Survey data from Bangladesh, India, Nepal and Sri Lanka collected during 2002-2003. We used multiple matching methods to match households where the respondent reported symptomatic or diagnosed angina with control households with similar propensity scores.

Results

Angina-affected households had significantly higher OOP health spending per person in the four weeks preceding the survey than matched controls, in Bangladesh (I$1.94, p = 0.04), in Nepal (I$4.68, p = 0.03) and in Sri Lanka (I$1.99, p < 0.01). Nearly half of this difference was accounted for by drug expenditures. Catastrophic spending, defined as the ratio of OOP health spending to total household expenditure in excess of 20%, was significantly higher in angina-affected households relative to matched controls in India (9.60%, p < 0.01), Nepal (4.90%, p = 0.02) and Sri Lanka (9.10%, p < 0.01). Angina-affected households significantly relied on borrowing or selling assets to finance OOP health expenses in Bangladesh (6%, p = 0.03), India (8.20%, p < 0.01) and Sri Lanka (7.80%, p = 0.01). However, impoverishment, non-medical consumption expenditure and employment status of the angina-affected individual remained mostly unaffected. We adjusted our estimates for comorbidities, but limitations on comorbidity data in the WHS mean that our results may be upwardly biased.

Conclusions

Households that had the respondent reporting angina in South Asia face an economic burden of OOP health expenses (primarily on drugs and other outpatient expenses), and tend to rely on borrowing or selling assets. Our analysis underscores the need to protect South Asian households from the financial burden of CVD.

【 授权许可】

   
2014 Alam and Mahal; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150304002029506.pdf 239KB PDF download
【 参考文献 】
  • [1]Dorland WAN: Dorland's Illustrated Medical Dictionary32: Dorland's Illustrated Medical Dictionary. Elsevier Health Sciences; 2011.
  • [2]Mathers C, Truelsen T, Begg S, Satoh T: Global Burden of Ischaemic Heart Disease in the Year 2000. In Global Burden of Disease 2000. Geneva: World Health Organization; 2004.
  • [3]Alwan A: Global Status Report on Noncommunicable Diseases 2010. Geneva: World Health Organization; 2011.
  • [4]Miranda J, Kinra S, Casas J, Davey Smith G, Ebrahim S: Non‐communicable diseases in low‐and middle‐income countries: context, determinants and health policy. Trop Med Int Health 2008, 13:1225-1234.
  • [5]Srtrong K, Mathers C, Leeder S, Beaglehole R: Preventing chronic diseases: how many lives can we save? Lancet 2005, 366:1578-1582.
  • [6]Adeyi O, Smith O, Robles S: Public Policy and the Challenge of Chronic Noncommunicable Diseases. World Bank: Washington, DC; 2007.
  • [7]Rao KD, Bhatnagar A, Murphy A: Socio-economic inequalities in the financing of cardiovascular & diabetes inpatient treatment in India. Indian J Med Res 2011, 133:57.
  • [8]Huffman MD, Rao KD, Pichon-Riviere A, Zhao D, Harikrishnan S, Ramaiya K, Ajay V, Goenka S, Calcagno JI, Caporale JE: A cross-sectional study of the microeconomic impact of cardiovascular disease hospitalization in four low-and middle-income countries. PLoS One 2011, 6:e20821.
  • [9]Murphy A, Mahal A, Richardson E, Moran AE: The economic burden of chronic disease care faced by households in Ukraine: a cross-sectional matching study of angina patients. Int J Equity Health 2013, 12:38. BioMed Central Full Text
  • [10]Alam K, Mahal A: Economic effect of angina on households in south Asia: a propensity score matching approach. Lancet 2012, 380:S11.
  • [11]Spertus JA, Jones P, McDonell M, Fan V, Fihn SD: Health status predicts long-term outcome in outpatients with coronary disease. Circulation 2002, 106:43-49.
  • [12]Javitz HS, Ward MM, Watson JB, Jaana M: Cost of illness of chronic angina. Am J Manag Care 2004, 10:S358-S369.
  • [13]The World Health Survey: Sampling guidelines for participating countries 2002. Geneva: World Health Organization; 2002.
  • [14]Rosenbaum PR, Rubin DB: The central role of the propensity score in observational studies for causal effects. Biometrika 1983, 70:41-55.
  • [15]Rose GA: The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Organ 1962, 27:645.
  • [16]The World Health Survey: Individual Questionnaire. Geneva: World Health Organization; 2002.
  • [17]Mathers C, Stevens G, Mascarenhas M: Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. Geneva: World Health Organization; 2009.
  • [18]Karlan D, Mobius M, Rosenblat T, Szeidl A: Trust and social collateral. Q J Econ 2009, 124:1307-1361.
  • [19]The World Health Survey: Household Questionnaire. Geneva: World Health Organization; 2002.
  • [20]Lu C, Chin B, Li G, Murray CJL: Limitations of methods for measuring out-of-pocket and catastrophic private health expenditures. Bull World Health Organ 2009, 87:238-244D.
  • [21]Xu K, Ravndal F, Evans DB, Carrin G: Assessing the reliability of household expenditure data: results of the World Health Survey. Health Policy 2009, 91:297-305.
  • [22]O’Donnell O, Van Doorsslaer E, Wagstaff A, Lindelow M: Analyzing Health Equity Using Household Survey Data: A Guide to Techniques and Their Implementation. World Bank: Washington, DC; 2008.
  • [23]Xu K, Evans DB, Kawabata K, Zeramdini R, Klavus J, Murray CJL: Household catastrophic health expenditure: a multicountry analysis. Lancet 2003, 362:111-117.
  • [24]Wagstaff A, Doorslaer EV: Catastrophe and impoverishment in paying for health care: with applications to Vietnam 1993–1998. Health Econ 2003, 12:921-933.
  • [25]Spertus JA, McDonell M, Woodman CL, Fihn SD: Association between depression and worse disease-specific functional status in outpatients with coronary artery disease. Am Heart J 2000, 140:105-110.
  • [26]Chen AY, Daley J, Thibault GE: Angina Patients’ ratings of current health and health without angina associations with severity of angina and comorbidity. Medical Decis Making 1996, 16:169-177.
  • [27]Tong B, Stevenson C: Comorbidity of Cardiovascular Disease, Diabetes and Chronic Kidney Disease in Australia. Australian Institute of Health and Welfare: Canbera; 2007.
  • [28]Hemingway H, Vahtera J, Virtanen M, Pentti J, Kivimäki M: Outcome of stable angina in a working population: the burden of sickness absence. Eur J Cardiovasc Prev Rehabil 2007, 14:373-379.
  • [29]Saksena P, Xu K, Elovainio R, Perrot J: Health Services Utilization and out-of-Pocket Expenditure in Public and Private Facilities in Lowincome Countries. In World Health Report. Geneva: World Health Organization; 2010.
  • [30]Fernando T, Rannan-Eliya RP, Jayasundara JMH: Sri Lanka Health Accounts: National Health Expenditures 1990-2006. In Health Expenditure Series No. 1. Colombo: Institute for Health Policy; 2009.
  • [31]Sadana R, D’Souza C, Hyder AA, Chowdhury AMR: Importance of health research in South Asia. BMJ 2004, 328:826-830.
  • [32]Selvaraj S, Karan AK: Why publicly-financed health insurance schemes are ineffective in providing financial risk protection. Econ Polit Wkly 2012, 47:61-68.
  • [33]Van Doorslaer E, O’Donnell O, Rannan-Eliya RP, Somanathan A, Adhikari SR, Akkazieva B, Garg CC, Harbianto D, Herrin AN, Huq MN: Paying out-of-Pocket for Health Care in Asia: Catastrophic and Poverty Impact. In EQUITAP Project: Working Paper # 2. Rotterdam, the Netherlands: Erasmus University; 2005.
  • [34]Russell S: Treatment-seeking behaviour in urban Sri Lanka: trusting the state, trusting private providers. Soc Sci Med 2005, 61:1396-1407.
  • [35]Gertler P, Gruber J: Insuring consumption against illness. Am Econ Rev 2002, 92:51-70.
  • [36]Beegle K: Labor effects of adult mortality in Tanzanian households. Econ Dev Cult Chang 2005, 53:655-683.
  • [37]Lindelow M, Wagstaff A: Health shocks in China: are the poor and uninsured less protected? In World Bank Policy Research Working Paper No 3740. Washington, DC: World Bank; 2005.
  • [38]Beegle K, De Weerdt J, Dercon S: Adult mortality and consumption growth in the age of HIV/AIDS. Econ Dev Cult Chang 2008, 56:299-326.
  • [39]Dercon S, Hoddinott J, Woldehanna T: Shocks and consumption in 15 Ethiopian villages, 1999-2004. J Afr Econ 2005, 14:559.
  • [40]Powell-Jackson T, Hoque ME: Economic consequences of maternal illness in rural Bangladesh. Health Econ 2012, 21:796-810.
  • [41]Alem Y, Söderbom M: Household-level consumption in urban ethiopia: the effects of a large food price shock. World Dev 2012, 40:146-162.
  • [42]Islam A, Maitra P: Health shocks and consumption smoothing in rural households: does microcredit have a role to play? J Dev Econ 2012, 97:232-243.
  • [43]Russell S: The economic burden of illness for households in developing countries: a review of studies focusing on malaria, tuberculosis, and human immunodeficiency virus/acquired immunodeficiency syndrome. AmJTrop Med Hyg 2004, 71:147-155.
  • [44]Asfaw A, Von Braun J: Is consumption insured against illness? Evidence on vulnerability of households to health shocks in rural Ethiopia. Econ Dev Cult Chang 2004, 53:115-129.
  • [45]Visaria P: Poverty and living standards in Asia. Popul Dev Rev 1980, 6:189-223.
  • [46]Anand S, Harris CJ: Choosing a welfare indicator. Am Econ Rev 1994, 84:226-231.
  • [47]Kimberlin CL, Winterstein AG: Validity and reliability of measurement instruments used in research. Am J Health Syst Pharm 2008, 65:2276-2284.
  文献评价指标  
  下载次数:12次 浏览次数:16次